Author:
Giuffrida Andrea,Leweke F Markus,Gerth Christoph W,Schreiber Daniela,Koethe Dagmar,Faulhaber Johannes,Klosterkötter Joachim,Piomelli Daniele
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference35 articles.
1. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS et al (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97: 8104–8109.
2. Andréasson S, Allebeck P, Engström A, Rydberg U (1987). Cannabis and schizophrenia. Lancet 2: 1483–1486.
3. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325: 1212–1213.
4. Arvanitis L, Bauer D, Rein W (2002). Results of the metatrial project: efficacy and tolerability of four novel compounds in schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol 5: S188.
5. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th DMS-IV edn. American Psychiatric Press Inc.: Washington, DC.
Cited by
392 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献